Click on the subcategory below to find drug monographs for that particular area.
Make prescribing decisions with our comparative charts and treatment algorithms.
Download or print easy-to-read disease leaflets for your patients.
Get valuable insight on select drug products and medically-relevant topics, courtesy of the pharmaceutical industry.
A novel blood-based biomarker test has been shown to predict with over 90% accuracy the likelihood of a healthy individual developing mild cognitive impairment or Alzheimer's disease within three years.
A prototype blood-based assay shows high specificity for variant Creutzfeldt-Jakob disease (vCJD).
About half a million deaths in the United States may be attributable to Alzheimer's disease (AD), more than five times as many as previously reported and similar to the number of deaths from heart disease and cancer.
A novel blood-based biomarker test has been shown to predict with over 90% accuracy the likelihood of a healthy individual developing mild cognitive impairment or Alzheimer's disease within three years.
When a magnet is placed on the skin, capillary walls relax, allowing for increased blood flow and oxygenation and removal of accumulated pain-producing prostaglandins.
A prototype blood-based assay shows high specificity for variant Creutzfeldt-Jakob disease (vCJD).
This module reviews all topics on the NCCPA examination blueprint relating to the Musculoskeletal, Neurologic, ...
Alzheimer’s disease is the most common form of dementia, affecting approximately 6% to 7% of ...
This activity briefly provides clinicians with key summarized issues from the 2013 meeting of the ...
